Genetica with its proprietary gene testing technology has been at the forefront of serving Asian’s population toward the inev ... itable precision medicine and personalized preventative care. Genetica provides its low-cost gene test solutions and decodes hundreds of genes and nearly a million variants to provide its users in-depth personalized reports on optimal plans for fitness and diet; children development and critical illness prevention (cancers, diabetes; strokes…) Head quartered in San Fransisco, and provide its low-cost services to Southeast Asian, Genetica has been one of the fastest growing direct-to-consumer gene testing technology company in the region. Genetica’s proprietary state-of-the-art technology is the achievement of marrying Machine Learning competency and Molecular Biology deep expertise, plus years and years of R&D in partnership with leading institutes including UCSF, Harvard Medical School, Stanford University, Cornell University; Illumina and Thermo Fisher. According to BCC Research dated December 2020 (Direct-to-consumer Genetic Testing Global Market and Technology), the lack of proprietary technology for Asian genomics decoding has led to a conservative projection of only 14% contribution of Asian genomics data in world database by 2025. The faster and cheaper we can close the gap, the more accessible personalized care and precision medicine it becomes for a majority of Asian people. We continue to look forward to partnering with those who genuinely understand the technology and set out to pursue positive social impact in a long-term manner. read more